MAPK3 and fragile X syndrome: The strongest evidence implicating disruption of ERK1/2 signaling in ASD comes from a number of single gene mutations that are associated with autism including Tuberous sclerosis, Fragile X syndrome, 16p11.2 (discussed in future sections in this review) and NF1 all ultimately leading to activation of ERK1/2.